Barroso EBC, Souza MC de, Araujo SRC de, Crocamo S. Dual anti-human epidermal growth factor receptortype 2 blockade with taxane as first-line treatment for HER2-positive breast cancer with visceral metastases: a technology incorporation assessment within the Brazilian Unified Health System. MAST [Internet]. 2026 Feb. 24 [cited 2026 Apr. 29];35(suppl.1). Available from: https://mastology.org/journal/article/view/1236